Paper36949046
To metabolomics and beyond: a technological portfolio to investigate cancer metabolism.
Danzi F and 6 others. Signal Transduct Target Ther, 2023. Cited by 182 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. To metabolomics and beyond: a technological portfolio to investigate cancer metabolism. Papers, record 36949046. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36949046
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Metabolomics | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Energy Metabolism | |
| Biomarkers |
Source PubMed
References308
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28,555,623 | Redesigning metabolism based on orthogonality principles. | Nat Commun | 2017 | https://conductscience.org/library/papers/28555623 | PubMed |
| 2 | 29,501,168 | A review of nanoscale LC-ESI for metabolomics and its potential to enhance the metabolome coverage. | Talanta | 2018 | https://conductscience.org/library/papers/29501168 | PubMed |
| 3 | 29,452,643 | Combinatorial CRISPR-Cas9 Metabolic Screens Reveal Critical Redox Control Points Dependent on the KEAP1-NRF2 Regulatory Axis. | Mol Cell | 2018 | https://conductscience.org/library/papers/29452643 | PubMed |
| 4 | 34,649,956 | Redox Regulation in Cancer Cells during Metastasis. | Cancer Discov | 2021 | https://conductscience.org/library/papers/34649956 | PubMed |
| 5 | 21,170,321 | Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. | PLoS One | 2010 | https://conductscience.org/library/papers/21170321 | PubMed |
| 6 | 35,022,194 | Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer. | J Immunother Cancer | 2022 | https://conductscience.org/library/papers/35022194 | PubMed |
| 7 | 21,742,802 | Fourier transform mass spectrometry. | Mol Cell Proteomics | 2011 | https://conductscience.org/library/papers/21742802 | PubMed |
| 8 | 32,883,000 | Entosis: From Cell Biology to Clinical Cancer Pathology. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32883000 | PubMed |
| 9 | 21,692,241 | Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. | Biochim Biophys Acta | 2011 | https://conductscience.org/library/papers/21692241 | PubMed |
| 10 | 30,613,774 | Improving the metabolic fidelity of cancer models with a physiological cell culture medium. | Sci Adv | 2019 | https://conductscience.org/library/papers/30613774 | PubMed |
| 11 | 21,706,701 | An introduction to mass spectrometry applications in biological research. | Biochem Mol Biol Educ | 2004 | https://conductscience.org/library/papers/21706701 | PubMed |
| 12 | 26,321,679 | Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. | Cell | 2015 | https://conductscience.org/library/papers/26321679 | PubMed |
| 13 | 22,079,244 | Recent and potential developments of biofluid analyses in metabolomics. | J Proteomics | 2012 | https://conductscience.org/library/papers/22079244 | PubMed |
| 14 | 25,037,503 | The pentose phosphate pathway and cancer. | Trends Biochem Sci | 2014 | https://conductscience.org/library/papers/25037503 | PubMed |
| 15 | 32,302,552 | Nitrogen Metabolism in Cancer and Immunity. | Trends Cell Biol | 2020 | https://conductscience.org/library/papers/32302552 | PubMed |
| 16 | 36,471,053 | Targeting DNA damage response pathways in cancer. | Nat Rev Cancer | 2023 | https://conductscience.org/library/papers/36471053 | PubMed |
| 17 | 26,965,202 | Emerging applications of metabolomics in drug discovery and precision medicine. | Nat Rev Drug Discov | 2016 | https://conductscience.org/library/papers/26965202 | PubMed |
| 18 | 1,562,763 | Milestones in magnetic resonance: 'a new method of measuring nuclear magnetic moment' . 1938. | J Magn Reson Imaging | 1992 | https://conductscience.org/library/papers/1562763 | PubMed |
| 19 | 23,163,809 | Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling. | J Proteome Res | 2013 | https://conductscience.org/library/papers/23163809 | PubMed |
| 21 | 34,339,935 | The limitless applications of single-cell metabolomics. | Curr Opin Biotechnol | 2021 | https://conductscience.org/library/papers/34339935 | PubMed |
Cited by130
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 182 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,890,802 | Progress of metabolomics-centric multi-omics research in medicine. | IMetaOmics | 2026 | https://conductscience.org/library/papers/42890802 | PubMed |
| 42,879,009 | Untargeted Metabolite Screening of Ewing Sarcoma Cells and Tissues with Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). | Methods Mol Biol | 2027 | https://conductscience.org/library/papers/42879009 | PubMed |
| 42,733,048 | Circulating Metabolite Signatures Associated With Amyloid Positivity, Cognitive Performance and Plasma P-tau181 Levels in Cognitively Unimpaired Older Adults. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42733048 | PubMed |
| 42,687,344 | 1H HR-MAS NMR Metabolomics in Combination With Transcriptomic Correlation Provides New Insights Into Metabolic Heterogeneity Across Breast Cancer Immunohistochemical Subtypes. | NMR Biomed | 2026 | https://conductscience.org/library/papers/42687344 | PubMed |
| 42,661,978 | Detection of Pancreatic Cancer via Specific Metabolite Markers: A Metabolomics Approach. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/42661978 | PubMed |
| 42,621,358 | Oncometabolites in Cancer Metabolism: Mechanistic Insights and Biomarker Potential- A Narrative Review. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/42621358 | PubMed |
| 42,599,532 | Unravelling the phytochemical complexity of neuroprotective plants: a metabolomics approach to Alzheimer's disease. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42599532 | PubMed |
| 42,465,542 | LC-MS-based serum metabolomics reveals distinct metabolic signatures in patients with intracerebral Hemorrhage. | Front Neurol | 2026 | https://conductscience.org/library/papers/42465542 | PubMed |
| 42,443,803 | Metabolomic profiling reveals key metabolic pathway alterations in monochorionic diamniotic twins with selective intrauterine growth restriction. | BMC Pregnancy Childbirth | 2026 | https://conductscience.org/library/papers/42443803 | PubMed |
| 42,397,597 | Metabolomics in breast cancer: insights into treatment responses, disease progression, and prognostic assessment. | Metabolomics | 2026 | https://conductscience.org/library/papers/42397597 | PubMed |
| 42,346,144 | The Interplay of Splicing and Metabolism in Cancer. | Cells | 2026 | https://conductscience.org/library/papers/42346144 | PubMed |
| 42,291,207 | ExIR enables prioritizing driver and biomarker genes from omics data in a reference free manner. | iScience | 2026 | https://conductscience.org/library/papers/42291207 | PubMed |
| 42,282,246 | Transforming cutting-edge healthcare: Emerging trends in metabolomics and drug design using artificial intelligence and big data methodologies. | Digit Health | 2026 | https://conductscience.org/library/papers/42282246 | PubMed |
| 42,192,865 | Multi Omics Integration in Colorectal Cancer: From Molecular Insights to Precision Oncology. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42192865 | PubMed |
| 42,144,528 | Tools and Technologies for Studying Cancer Metabolism. | Cancer Treat Res | 2026 | https://conductscience.org/library/papers/42144528 | PubMed |
| 42,041,718 | Metabolomic Insights into Head and Neck Cancer: Recent Advances and Future Directions. | Curr Oncol | 2026 | https://conductscience.org/library/papers/42041718 | PubMed |
| 41,999,538 | Linking metabolism and metastasis: elevated α-hydroxybutyric acid in oral squamous cell carcinoma patients with lymph node metastasis. | Metabolomics | 2026 | https://conductscience.org/library/papers/41999538 | PubMed |
| 41,975,495 | The metabolic profiles of cancer stem cells. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/41975495 | PubMed |
| 41,951,891 | Multi-omics approaches reveal erythroid progenitor cell in cancer: from passive bystander to active player. | Oncogene | 2026 | https://conductscience.org/library/papers/41951891 | PubMed |
| 41,943,831 | Suppression of ASNS expression by VHL-mediated ubiquitination hinders the progression of renal cell carcinoma through enhancing JUP expression and inhibiting PI3K-AKT and MAPK pathways. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/41943831 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36949046
GET https://conductscience.org/api/papers/v1/36949046/references?page=2